by Maria Zannes | Apr 6, 2016 | News
APRIL 6, 2016 As published in the San Antonio Express News By Peggy O’Hare, Staff Writer The problem with early lung cancer screening is the unnecessary worry for the 97 percent of patients flagged with suspicious results — that ultimately turn out to be inaccurate....
by Maria Zannes | Apr 4, 2016 | Press Releases
APRIL 4, 2016 (SAN ANTONIO, TX) bioAffinity Technologies, a privately held cancer diagnostics company, today announced that Vivienne Rebel, M.D., Ph.D., has joined the Company as Executive Vice President of Research and Development (R&D) and Chief Medical and...
by Maria Zannes | Feb 1, 2016 | Events
FEBRUARY 1, 2016 @8:00 am- 5:00 pm Maria Zannes, President & Chief Executive Officer February 2016 Quarterly Luncheon of the Texas Research & Technology Foundation in San Antonio Omni Hotel San Antonio, TX United States Texas Research & Technology...
by Maria Zannes | Dec 16, 2015 | News
DECEMBER 16, 2015 As published in the San Antonio Business Journal By W. Scott Bailey The People’s Republic of China has awarded a Certificate of Invention Patent to bioAffinity Technologies for its proprietary CyPath® assay, which could have a profound impact on...
by Maria Zannes | Dec 14, 2015 | Press Releases
DECEMBER 14, 2015 (SAN ANTONIO, TX ) bioAffinity Technologies announced the People’s Republic of China awarded a Certificate of Invention Patent for the Company’s proprietary CyPath® assay, a bio-label that preferentially binds to cancer cells and labels them a...
